Pharmaids Pharmaceuticals Limited (BOM:524572)
32.28
+3.54 (12.32%)
At close: Jun 17, 2026
Pharmaids Pharmaceuticals Revenue
In the fiscal year ending March 31, 2026, Pharmaids Pharmaceuticals had annual revenue of 278.82M INR with 42.89% growth. Pharmaids Pharmaceuticals had revenue of 72.83M in the quarter ending March 31, 2026, with 50.65% growth.
Revenue
278.82M
Revenue Growth
+42.89%
P/S Ratio
4.08
Revenue / Employee
9.96M
Employees
28
Market Cap
1.14B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 278.82M | 83.69M | 42.89% |
| Mar 31, 2025 | 195.14M | 42.14M | 27.54% |
| Mar 31, 2024 | 153.00M | - | - |
| Mar 31, 2023 | - | - | - |
| Mar 31, 2022 | 39.39M | -46.12M | -53.93% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bilcare | 7.34B |
| Bal Pharma | 3.12B |
| Parnax Lab | 2.49B |
| Lactose (India) | 1.63B |
| Aayush Wellness | 1.55B |
| Makers Laboratories | 1.42B |
| Godavari Drugs | 1.07B |
| Concord Drugs | 787.37M |
Pharmaids Pharmaceuticals News
- 20 days ago - Pharmaids Pharmaceuticals Slides: Q4 2026 - Filings
- 4 months ago - Pharmaids Pharmaceuticals Quarterly report: Q3 2026 - Filings
- 7 months ago - Pharmaids Pharmaceuticals Quarterly report: Q2 2026 - Filings
- 11 months ago - Pharmaids Pharmaceuticals Quarterly report: Q1 2026 - Filings